Sfoglia per Autore
Should genetic analysis in newborn screening and a heterozygote test for hyperphenylalaninaemia be recommended? An Italian study
1999 A. Rottoli, M.L. Gianní, E. Verduci, M.L. Biondi, L. Fiori, M. Giovannini, E. Riva
Breastfeeding rates among hyperphenylalaninemic infants
2000 C. Agostoni, E. Verduci, L. Fiori, E. Riva, M. Giovannini
Sonographic findings in type I glycogen storage disease
2001 C. Pozzato, A. Botta, C. Melgara, L. Fiori, M.L. Giannì, E. Riva
Phenylalanine hydroxylase mutations and phenylalanine-tyrosine metabolism in heterozygotes for phenylalanine hydroxylase deficiency
2002 E. Verduci, E. Riva, C. Agostoni, S. Leviti, L. Fiori, A.M. Lammardo, M.L. Biondi, M. Giovannini
Body mass index rebound and overweight at 8 years of age in hyperphenylalaninaemic children
2004 S. Scaglioni, E. Verduci, L. Fiori, A. Lammardo, S. Rossi, G. Radaelli, E. Riva, M. Giovannini
Ecografia dell'addome nelle malattie ereditarie del metabolismo dei carboidrati
2005 C. Pozzato, A. Curti, G. Radaelli, L. Fiori, S.A. Rossi, E. Riva, G. Cornalba
Plasma and cerebral phenylalanine in PKU adult patients : any correlation with IQ or genotype?
2005 M. Giovannini, L. Fiori, B. Fiege, E. Salvatici, G. Calabrese, A. Falini
Incidence of BH4-responsiveness in phenylalanine-hydroxylase-deficient Italian patients
2005 L. Fiori, B. Fiege, E. Riva, M. Giovannini
Double blind placebo control trial of large neutral amino acids in treatment of PKU: effect on blood phenylalanine
2007 R. Matalon, K. Michals-Matalon, G. Bhatia, A.B. Burlina, A.P. Burlina, C. Braga, L. Fiori, M. Giovannini, E. Grechanina, P. Novikov, J. Grady, S.K. Tyring, F. Guttler
Phenylketonuria : dietary and therapeutic challenges
2007 M. Giovannini, E. Verduci, E. Salvatici, L. Fiori, E. Riva
Treating Phenylketonuria : a single centre experience
2007 M. Giovannini, E. Riva, E. Salvatici, L. Fiori, S. Paci, E. Verduci, C. Agostoni
Psychosocial distress in PKU female patients with good and bad metabolic control
2008 M. Giovannini, P. Mirazita, S. Paci, L. Fiori, E. Iapichino, M. Mandelli, E. Riva
Severe PRPS Deficienty in an Adult Lawyer with Normal IQ
2009 M. Giovannini, L. Fiori, E. Salvatici, S. Paci, M. Bonza, E. Riva
Non-thyroidal illness syndrome and SARS-CoV-2-associated multisystem inflammatory syndrome in children
2021 V. Calcaterra, G. Biganzoli, D. Dilillo, S. Mannarino, L. Fiori, G. Pelizzo, E. Zoia, V. Fabiano, P. Carlucci, A. Camporesi, C. Corti, G. Mercurio, F. Izzo, E. Biganzoli, G. Zuccotti
Neurological Involvement in Multisystem Inflammatory Syndrome in Children: Clinical, Electroencephalographic and Magnetic Resonance Imaging Peculiarities and Therapeutic Implications. An Italian Single-Center Experience
2022 S.M. Bova, L. Serafini, P. Capetti, A.R. Dallapiccola, C. Doneda, A. Gadda, L. Lonoce, A. Vittorini, S. Mannarino, P. Veggiotti, S. Olivotto, E. Basso, R. Lavatelli, R. Previtali, L. Parenti, G. Zuccotti, L. Fiori, E. Zoia, A. Camporesi, V. Diotto, M. Gambino
Seizures may be an early sign of acute COVID-19, and the Omicron variant could present a more epileptogenic profile
2022 S.M. Bova, L. Serafini, I. Serati, L. Fiori, P. Veggiotti
Glycomacropeptide (GMP) rescued the oxidative and inflammatory activity of free L-AAs in human Caco-2 cells: New insights that support GMP as a valid and health-promoting product for the dietary management of phenylketonuria (PKU) patients
2023 C. Lammi, C. Bollati, L. Fiori, J. Li, M. Fanzaga, L. D’Adduzio, M. Tosi, A. Burlina, G. Zuccotti, E. Verduci
Association between cobalamin deficiency detected through newborn screening and creatine levels in mothers and their offspring in the first age stages
2023 V.M. Tagi, L. Fiori, C. Montanari, M. Tosi, M. Gambino, L. Alberti, C. Cereda, G. Zuccotti, E. Verduci
Relazione tra deficit di vitamina B12 evidenziato allo screening neonatale e valori di creatina nella diade -mamma bambino nelle prime epoche di vita
2023 L. Fiori, C. Montanari, V. Tagi, M. Gambino, L. Alberti, C. Cereda, E. Bonaventura, D. Tonduti, G. Zuccotti, E. Verduci
Effetti a breve e medio termine della sospensione della terapia con Olipudasi alfa in un bambino affetto da deficit di sfingomielinasi acida neuroviscerale cronica
2023 C. Montanari, V.M. Tagi, M. Gambino, E. Verduci, G. Zuccotti, L. Fiori
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile